Erratum: The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-α-induced transcriptional repression of cyclin A (Journal of Clinical Investigation (2005) 115 (1785-1796) DOI: 10.1172/JCI22849);The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-α-induced transcriptional repression of cyclin A

Journal of Clinical Investigation

Volumn 115, Issue 7, 2005, Pages 1785-1796

  Kishore, Raj ^a,b   Qin, Gangjian ^a   Luedemann, Corinne ^a   Bord, Evelyn ^a   Hanley, Allison ^a   Silver, Marcy ^a   Gavin, Mary ^a   Goukassain, David ^a   Losordo, Douglas W ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYTOSKELETON PROTEIN; EZRIN; RHO KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME INDUCTION; GENE FUNCTION; GENE OVEREXPRESSION; HINDLIMB; HUMAN; HUMAN CELL; IN VIVO STUDY; LIMB ISCHEMIA; MOUSE; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; PROTEIN TRANSPORT; TRANSCRIPTION REGULATION; TRANSCRIPTION TERMINATION;

EID: 22144443812     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI22849E1     Document Type: Erratum

References (59)

1. Ausprunk, D.H., and Folkman, J. 1977. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc. Res. 14:53-65.
2. Winkles, J.A., et al. 1987. Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor). Proc. Natl. Acad. Sci. U. S. A. 84:7124-7128.
3. Modur, V., Zimmerman, G.A., Prescott, S.M., and McIntyre, T.M. 1996. Endothelial cell inflammatory responses to tumor necrosis factor alpha. Ceramide-dependent and -independent mitogen-activated protein kinase cascades. J. Biol. Chem. 271:13094-13102.
4. Leibovich, S.J., et al. 1987. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature. 329:630-632.
5. Lopez-Marure, R., Bernal, A.E., and Zentella, A. 1997. Interference with c-myc expression and RB phosphorylation during TNF-mediated growth arrest in human endothelial cells. Biochem. Biophys. Res. Commun. 236:819-824.
6. Spyridopoulos, I., et al. 1998. Restoration of E2F expression rescues vascular endothelial cells from tumor necrosis factor-alpha-induced apoptosis. Circulation. 98:2883-2890.
7. Krasinski, K., Spyridopoulos, I., Kearney, M., and Losordo, D.W. 2001. In vivo blockade of tumor necrosis factor-alpha accelerates functional endothelial recovery after balloon angioplasty. Circulation. 104:1754-1756.
8. Lopez-Marure, R., Ventura, J.L., Sanchez, L., Montano, L.F., and Zentella, A. 2000. Ceramide mimics tumour necrosis factor-alpha in the induction of cell cycle arrest in endothelial cells. Induction of the tumour suppressor p53 with decrease in retinoblastoma/protein levels. Eur. J. Biochem. 267:4325-4333.
9. Kishore, R., Spyri-dopoulos, I., Luedemann, C., and Losordo, DAV. 2002. Functionally novel tumor necrosis factor-alpha-modulated CHR-binding protein mediates cyclin A transcriptional repression in vascular endothelial cells. Circ. Res. 91:307-314.
10. Vaheri, A., et al. 1997. The ezrin protein family: membrane-cytoskeleton interactions and disease associations [review]. Curr. Opin. Cell Biol. 9:659-666.
11. Bretscher, A., Reczek, D., and Berryman, M. 1997. Ezrin: a protein requiring conformational activation to link microfilaments to the plasma membrane in the assembly of cell surface structures. J. Cell Sci. 110:3011-3018.
12. Tsukita, S., and Yonemura, S. 1999. Cortical actin organization: lessons from ERM (ezrin/radixin/ moesin) proteins. J. Biol. Chem. 274:34507-34510.
13. Matsui, T., Yonemura, S., and Tsukita, S. 1999. Activation of ERM proteins in vivo by Rho involves phosphatidyl-inositol 4-phosphate 5-kinase and not ROCK kinases. Curr. Biol. 9:1259-1262.
14. Gary, R., and Bretscher, A. 1995. Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding sice. Mol. Biol. Cell. 6:1061-1075.
15. Paglini, G., Kunda, P., Quiroga, S., Kosik, K., and Caceres, A. 1998. Suppression of radixin and moesin alters growth cone morphology, motility, and process formation in primary cultured neurons. J. Cell Biol. 143:443-455.
16. Louvet-Vallee, S. 2000. ERM proteins: from cellular architecture to cell signaling. Biol. Cell. 92:305-316.
17. Gautreau, A., Louvard, D., and Arpin, M. 2002. ERM proteins and NF2 tumor suppressor: the Yin and Yang of cortical actin organization and cell growth signaling [review]. Curr. Opin. Cell Biol. 14:104-109.
18. Wojciak-Stothard, B., Entwiscle, A., Garg, R., and Ridlev, A.J. 1998. Regulation of TNF-alpha-induced reorganization of the actin cytoskeleton and cell-cell junctions by Rho, Rac, and Cdc42 in human endochelial cells. J. Cell. Physiol. 176:150-165.
19. Petrache, I., et al. 2003. Caspase-dependent cleavage of myosin light chain kinase (MLCK) is involved in TNF-alpha-mediated bovine pulmonary endothelial cell apoptosis. FASEB J. 17:407-416.
20. Couffinhal, T., et al. 1998. Mouse model of angiogenesis. Am. J. Pathol. 152:1667-1679.
21. Sato, N., Funayama, N., Nagafuchi, A., Yonemura, S., and Tsukita, S. 1992. A gene family consisting of ezrin, radixin and moesin. Its specific localization at actin filament/plasma membrane association sites J. Cell Sci. 103:131-143.
22. Berryman, M., Franck, Z., and Bretscher, A. 1993. Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells. J. Cell Sci. 105:1025-1043.
23. Amieva, M.R., Wilgenbus, K.K., and Furthmayr, H. 1994. Radixin is a component of hepatocyte microvilli in situ. Exp. Cell Res. 210:140-144.
24. Tsukita, S., Oishi, K., Sato, N., Sagara, J., and Kawai, A. 1994. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J. Cell Biol. 126:391-401.
25. Jiang, W.G., and Hiscox, S. 1996. Cytokine regulation of ezrin expression in the human colon cancer cell line HT29. Anticancer Res. 16:861-865.
26. Chen, Z., et al. 2001. Ovarian epithelial carcinoma tyrosine phosphorylation, cell proliferation, and ezrin translocation are stimulated by interleukin 1alpha and epidermal growth factor. Cancer. 92:3068-3075.
27. Bretscher, A. 2000. The cytoskeleton: from regulation to function. Conference: the 15th Meeting of the European Cytoskeleton Forum. EMBO Rep. 1:473-476.
28. Kaul, S.C., et al. 1999. Identification of a 55-kDa ezrin-related protein that induces cytoskeletal changes and localizes to the nucleolus. Exp. Cell Res. 250:51-61.
29. Wadham, C., Gamble, J.R., Vadas, M.A., and Khew-Goodall, Y. 2000. Translocation of protein tyrosine phosphatase Pez/PTPD2/PTP36 to the nucleus is associated with induction of cell proliferation. J. Cell Sci. 113:3117-3123.
30. Schmucker, B., Tang, Y., and Kressel, M. 1999. Novel alternatively spliced isoforms of the neurofibromatosis type 2 tumor suppressor are targeted to the nucleus and cytoplasmic granules. Hum. Mol. Genet. 8:1561-1570.
31. Ng, T., et al. 2001. Ezrin is a downstream effector of trafficking PKC-integrin complexes involved in the control of cell motility. EMBO J. 20:2723-2741.
32. Kondo, T., et al. 1997. ERM (ezrin/radixm/moesin)-based molecular mechanism of microvillar breakdown at an early stage of apoptosis. J. Cell Biol. 139:749-758.
33. Parlato, S., et al. 2000. CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J. 19:5123-5134.
34. Wang, K.C., Cheng, A.L., Chuang, S.E., Hsu, H.C., and Su, I.J. 2000. Retinoic acid-induced apoptotic pathway in T-cell lymphoma: identification of four groups of genes with differential biological functions. Exp. Hematol. 28:1441-1450.
35. Gautreau, A., Poullet, P., Louvard, D., and Arpin, M. 1999. Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. U. S. A. 96:7300-7305.
36. Ohtani, K., et al. 2002. Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma. Cancer Lett. 179:79-86.
37. Crepaldi, T., Gautreau, A., Comoglio, P.M., Louvard, D., and Arpin, M. 1997. Ezrin is an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cells. J. Cell Biol. 138:423-434.
38. Kaui, S.C., Mitsui, Y., Komatsu, Y., Reddel, R.R., and Wadhwa, R. 1996. A highly expressed 81 kDa protein in immortalized mouse fibroblast: its proliferative function and identity with ezrin. Oncogene. 13:1231-1237.
39. Hiscox, S., and Jiang, W.G. 1999. Ezrin regulates cell-cell and cell-matrix adhesion, a possible role with E-cadherin/beta-catenm. J. Cell Sci. 112:3081-3090.
40. Rozenblatt-Rosen, O., et al. 2002. Induction of chondrocyte growth arrest by FGF: transcriptional and cytoskeletal alterations. J. Cell Sci. 115:553-562.
41. Gutmann, D.H., et al. 1999. Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesion and spreading. Hum. Mol. Genet. 8:267-275.
42. Gutmann, D.H., Hirbe, A.C., Huang, Z.Y., and Haipek, C.A. 2001. The protein 4.1 tumor suppressor, DAL-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion. Neurobiol. Dis. 8:266-278.
43. Morrison, H., et al. 2001. The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev. 15:968-980.
44. Nakamura, F., Amieva, M.R., and Furthmayr, H. 1995. Phosphorylation of threonine 558 in the carboxyl-terminal actin-binding domain of moesin by thrombin activation of human platelets. J. Biol. Chem. 270:31377-31385,
45. Perez, O.D., et al. 2002. Activation of the PK5/AKT pathway by ICAM-2. Immunity. 16:51-65.
46. Tran, Y.K., et al. 1999. A novel member of the NF2/ ERM/4.1 superfamily with growth suppressing properties in lung cancer. Cancer Res. 59:35-43.
47. Shaw, R.J., Henry, M., Solomon, F., and Jacks, T. 1998. RhoA-dependent phosphorylation and relocalization of ERM proteins into apical membrane/actin protrusions in fibroblasts. Mol. Biol. Cell. 9:403-419.
48. Jeon, S., et al. 2002. RhoA and Rho kinase-dependent phosphorylation of moesin at Thr-558 in hippocampal neuronal cells by glutamate. J. Biol. Chem. 277:16576-16584.
49. Van Aelst, L., and D'Souza-Schorey, C. 1997. Rho GTPases and signaling networks. Genes Dev. 11:2295-2322.
50. Folkman, J., and Shing, Y. 1992. Angiogenesis. J. Biol. Chem. 267:10931-10934.
51. Lindner, V., and Reidy, M.A. 1996. Expression of VEGF receptors in arteries after endothelial injury and lack of increased endothelial regrowth in response to VEGF. Arterioscler Thromb. Vasc. Biol. 16:1399-1405.
52. Clausell, N., et al. 1995. Expression of tumor necrosis factor and accumulation of fibronectin in coronary artery restenosis lesions retrieved by atherectomy. Br. Heart J. 73:534-539.
53. Morishige, K., et al. 2001. Adenovirus-mediated transfer of dominant-negative rho-kinase induces a regression of coronary arteriosclerosis in pigs in vivo. Arterioscler. Thromb. Vasc. Biol. 21:548-554.
54. Eco, Y., et al. 2000. Gene Transfer of dominant negative Rho kinase suppresses neointimal formation after balloon injury in pigs. Am. J. Physiol. Heart Circ. Physiol. 278:H1744-H1750.
55. Algrain, M., Turunen, O., Vaheri, A., Louvard, D., and Arpin, M. 1993. Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker. J. Cell Biol. 120:129-139.
56. McKallip, R., Li, R., and Ladisch, S. 1999. Tumor gangliosides inhibit the tumor-specific immune response. J. Immunol. 163:3718-3726.
57. Goukassian, D.A., et al. 2003. Engineering the response to vascular injury: divergent effects of deregulated E2F1 expression on vascular smooth muscle cells and endothelial cells result in endothelial recovery and inhibition of neointimal growth. Circ. Res. 93:162-169.
58. Yamaguchi J., et al. 2003. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation. 107:1322-1328.
59. Takaishi, K., Matozaki, T., Nakano, K., and Takai, Y. 2000. Multiple downstream signalling pathways from ROCK, a target molecule of Rho small G protein, in reorganization of the actin cytoskeleton in Madin-Darby canine kidney cells. Genes Cells. 5:929-936.